Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Overwhelming post-splenectomy sepsis in patients with asplenia and hyposplenia: a retrospective cohort study

Chong J, Jones P, Spelman D, Leder K, Cheng AC

(2017), Epidemiol Infect, 145(2), 397-400

DOI: 10.1017/S0950268816002405

Donor-Derived Mycoplasma hominis and an Apparent Cluster of M. hominis Cases in Solid Organ Transplant Recipients

Smibert OC, Wilson HL, Sohail A, Narayanasamy S, Schultz MB, Ballard SA, Kwong JC, de Boer J, Morrissey CO, Peleg AY, Snell GI, Paraskeva MA, Jenney AWJ

(2017), Clin Infect Dis, 65(9), 1504-8

DOI: 10.1093/cid/cix601

Australasian Society for Infectious Diseases: low value interventions

Spelman D, Jenney AW, Burgner DP

(2017), Med J Aust, 206(7), 282-3

DOI: 10.5694/mja16.01427

An evidence-based approach to myeloma bone disease

Bingham N, Reale A, Spencer A

(2017), Curr Hematol Malig Rep, 12(2), 109-18

DOI: 10.1007/s11899-017-0370-5

The incidence and natural history of dasatinib complications in the treatment of chronic myeloid leukemia

Fox LC, Cummins KD, Costello B, Yeung D, Cleary R, Forsyth C, Tatarczuch M, Burbury K, Motorna O, Shortt J, Fleming S, McQuillan A, Schwarer A, Harrup R, Holmes A, Ratnasingam S, Chan KL, Hsu WH, Ashraf A, Putt F, Grigg A

(2017), Blood Adv, 1(13), 802-11

DOI: 10.1182/bloodadvances.2016003889

Factor VIII inhibitor eradication with bortezomib in acquired haemophilia A

McFadyen JD, Tran H, Kaplan ZS

(2017), Br J Haematol, 178(6), 986-7

DOI: 10.1111/bjh.14185

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Lee OL, Horvath N, Lee C, Joshua D, Ho J, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Talaulikar D, Brown R, Augustson B, Ling S, Jaksic W, Gibson J, Kalff A, Johnston A, Kalro A, Ward C, Prince HM, Zannettino A

(2017), Intern Med J, 47(8), 938-51

DOI: 10.1111/imj.13502

Treatment of patients with Waldenstràm macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group

Talaulikar D, Tam CS, Joshua D, Ho JP, Szer J, Quach H, Spencer A, Harrison S, Mollee P, Roberts AW, Horvath N, Lee C, Zannettino A, Brown R, Augustson B, Jaksic W, Gibson J, Kalff A, Johnston A, Trotman J, Kalro A, Grigoriadis G, Ward C, Prince HM

(2017), Intern Med J, 47(1), 35-49

DOI: 10.1111/imj.13311

Gastrointestinal carriage is a major reservoir of Klebsiella pneumoniae infection in intensive care patients

Gorrie CL, Mirceta M, Wick RR, Edwards DJ, Thomson NR, Strugnell RA, Pratt NF, Garlick JS, Watson KM, Pilcher DV, McGloughlin SA, Spelman DW, Jenney AWJ, Holt KE

(2017), Clin Infect Dis, 65(2), 208-15

DOI: 10.1093/cid/cix270

Clinical characteristics and laboratory identification of Aerococcus infections: an Australian tertiary centre perspective

Narayanasamy S, King K, Dennison A, Spelman DW, Aung AK

(2017), Int J Microbiol, 2017, 5684614

DOI: 10.1155/2017/5684614

Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand

Kanhutu K, Jones P, Cheng AC, Grannell L, Best E, Spelman D

(2017), Intern Med J, 47(8), 848-55

DOI: 10.1111/imj.13348

Partial response after induction chemotherapy has clinical relevance in acute myeloid leukaemia

Fleming S, Ong DM, Jackson K, Avery S, Mollee P, Marlton P, Kennedy G, Wei AH

(2017), Br J Haematol, 177(2), 328-3 0

Risk factors associated with urinary tract infections in intensive care patients

Lee EK, Teo A, Land G, Borrell S, Spelman D, Leong T, Cheng AC

(2016), Infect Dis Health, 21(2),

Plasma macrophage migration inhibitor factor is elevated in response to myocardial ischemia

Fan F, Fang L, Moore XL, Xie X, Du XJ, White DA, O'Brien J, Thomson H, Wang J, Schneider HG, Ellims A, Barber TW, Dart AM

(2016), J Am Heart Assoc, 5(7),

Impact of high-sensitivity troponin I testing with sex-specific cutoffs on the diagnosis of acute myocardial infarction

Trambas C, Pickering JW, Than M, Bain C, Nie L, Paul E, Dart A, Broughton A, Schneider HG

(2016), Clin Chem, 62(6),

Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint

Smith JD, Raines G, Schneider HG

(2016), Clin Chem Lab Med, 54(6),

Taenia solium taeniasis and cysticercosis in Southeast Asia

Aung AK, Spelman DW

(2016), Am J Trop Med Hyg, 94(5),

Targeting plasma cells: are we any closer to a panacea for diseases of antibody-secreting cells?

Low M, Infantino S, Grigoriadis G, Tarlinton D

(2016), Immunol Rev, 270(1),

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Vosaroxin plus cytarabine versus placebo plus cytarabine in patients with first relapsed or refractory acute myeloid leukaemia (VALOR): a randomised, controlled, double-blind, multinational, phase 3 study

Ravandi F, Ritchie EK, Sayar H, Lancet JE, Craig MD, Vey N, Strickland SA, Schiller GJ, Jabbour E, Erba HP, Pigneux A, Horst HA, Recher C, Klimek VM, Cortes J, Roboz GJ, Odenike O, Thomas X, Havelange V, Maertens J, Derigs HG, Heuser M, Damon L, Powell BL, Gaidano G, Carella AM, Wei A, Hogge D, Craig AR, Fox JA, Ward R, Smith JA, Acton G, Mehta C, Stuart RK, Kantarjian HM

(2015), Lancet Oncol, 16(9), 1025-36

9 10 11 12 13